Drug · DIN 02241047
VARILRIX
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since March 2, 2026; first marketed April 9, 2003.
- Drug Identification Number (DIN)
- 02241047
- Company (DIN owner)
- Glaxosmithkline IncMississauga, Ontario, Canada
- Schedule
- Schedule D
- Dosage form
- Powder For Solution
- Route
- Subcutaneous
- Therapeutic class (ATC)
- Varicella, live attenuated J07BK01
- Class
- Human
- Record last updated
- March 25, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| VARICELLA-ZOSTER VIRUS LIVE ATTENUATED (OKA-STRAIN) | 1995.26231 PFU | 0.5 ML |
Notices of Compliance
Health Canada approvals that name this DIN.
- August 22, 2001: NOC 2370New Drug Submission (NDS) · Change in manufacturer name
- October 13, 1999: NOC 1879New Drug Submission (NDS)